Welcome. If you're a registered user, please log-in. If not, please sign-up.

Impurities 2011

Optimising the effectiveness of your detection, identification and control strategies for impurities

Key Themes:

  • Essential regulatory updates
  • Synthesising the API: managing impurities
  • Detecting, identifying and quantifying impurities
  • Manufacturing the finished product: managing impurities
  • Controlling impurities

The programme for this conference is currently being put together, if you would be interested in participating or would like more information please contact rachael.mulcaster@informa.com

Speaker Panel

Speaker Panel

Piet Christiaens Scientific Director Toxikon Europe, Belgium

Rolf Schulte Oestrich Head of Analytical Development F. Hoffmann-La Roche AG, Switzerland

Karen Alsante Research Fellow Pfizer, USA

Mark Argentine Senior Research Advisor, Analytical Sciences R&D Eli Lilly, USA

Philippe Lienard Head of Early Development Unit Sanofi-Aventis, France

Xavier Molins Head of R&D and Regulatory Affairs (EU) Bimeda Ireland

Rui Cerdeira Head of QC Bial Portela Ca SA, Portugal

Brian Pack Research Advisor Eli Lilly, USA

 

  • Simeon Gill, Pharmaceutical Assessor, MHRA, UK
  • Antonio Giordani, Director, R&D Chemistry Drug Development & OS, Rottapharm, Italy
  • Simon Hamilton, Research Fellow, Merck, UK
  • Thomas Anderson, Associate Principal Scientist, AstraZeneca, Sweden
  • Jesper Larsen, Specialist, Quality SOE, Lundbeck, Denmark

Who should attend?

Heads of Department, Directors, Managers, Associates, Specialists and Coordinators from:

  • Analytical chemistry
  • Structural chemistry
  • Analytical Validation
  • Pharmaceutical Development
  • Toxicology
  • Stability Testing
  • QA/QC
  • Technical Affairs
  • Pre-clinical Safety
  • Safety Pharmacology
  • Analytical R&D

Great Networking!

Don’t miss this opportunity to discuss challenges, solutions and new opportunities with fellow colleagues from industry

Promotional Opportunities!

For information on our wide-range of tailored sponsorship solutions, please contact: Chamatkar Sandhu, Email: chamatkar.sandhu@informa.com

..

Spotlight Session Sponsor

..
..
..
..

Media Partners

..
..
..

Dates and Venues

14 Sep 2011 - 15 Sep 2011

Angelo Hotel Prague

Spotlight Session Sponsor

Spotlight Session Sponsor

New Speaker!

Extractable & Leachable Testing for Pharmaceutical Container/Closure Systems

Designing the Right Testing Strategy for Identification and Quantification

  • Introduction: Definitions and Regulatory Requirements
  • Analytical Methods required for Extractables & Leachables Research
  • The TOX-RAY Screener Database, assisting in the unique identification of >2000 Extractables
  • GC-ToF and LC-Accurate Mass Measurements: necessary tools in the further Identification of Unkown Compounds
  • Confirmation of the identity of Extractables and Leachables through Organic Synthesis
  • Case Studies  

Dr. Piet Christiaens, Scientific Director, Toxikon Europe, Belgium

www.toxikon.be

Feeds
rss
Like
Share
twitterfacebooklinkedinemail

Download Latest Information Now

(updated 22 May 2013)